ICD-10 Coding for Heparin-Induced Thrombocytopenia(D75.82, D75.821, D75.821B)
Learn about the ICD-10 coding for Heparin-Induced Thrombocytopenia (HIT), including immune and non-immune types, documentation requirements, and coding pitfalls.
Complete code families applicable to Heparin-Induced Thrombocytopenia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D75.822 | Immune-mediated heparin-induced thrombocytopenia | Use when immune-mediated HIT is confirmed by laboratory tests. |
|
| D75.821 | Non-immune heparin-induced thrombocytopenia | Use when HIT is non-immune and resolves without intervention. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHeparin-Induced Thrombocytopenia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Heparin-Induced Thrombocytopenia.
Failing to link heparin use to thrombocytopenia
Impact
Clinical: Misdiagnosis of HIT type., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement.
Mitigation
Ensure all documentation links heparin use to platelet changes.
Using unspecified codes when specific ones apply
Impact
Reimbursement: May affect DRG assignment and reimbursement rates., Compliance: Leads to non-compliance with coding guidelines., Data Quality: Reduces accuracy of clinical data.
Mitigation
Ensure documentation specifies the type of HIT for accurate coding.
Use of unspecified codes
Impact
High risk of audit if unspecified codes are used when specific ones apply.
Mitigation
Ensure documentation specifies HIT type and supporting lab results.